Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Alembic Pharma's Bioequivalence facility
USFDA inspection at Emcure Pharmaceuticals API facility
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Observations are largely around improvement of procedures and practices
The USFDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated
The Alathur facility specializes in the production of Cephalosporin antibiotics
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
Subscribe To Our Newsletter & Stay Updated
